Source: American heart journal. Unidade: FM
Subjects: COVID-19, TROMBOSE, REPLICAÇÃO VIRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HESS, Connie N. et al. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. American heart journal, v. 246, p. 136-143, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2021.12.010. Acesso em: 18 ago. 2024.APA
Hess, C. N., Capell, W. H., Bristow, M. R., Ruf, W., Szarek, M., Morrow, D. A., et al. (2022). Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. American heart journal, 246, 136-143. doi:10.1016/j.ahj.2021.12.010NLM
Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial [Internet]. American heart journal. 2022 ; 246 136-143.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.ahj.2021.12.010Vancouver
Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial [Internet]. American heart journal. 2022 ; 246 136-143.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.ahj.2021.12.010